Tuesday, January 24, 2023

< + > The End Of Obesity

Since its 2021 launch, Novo Nordisk’s Wegovy set the stage for the next generation of anti-obesity drugs that target the gut’s weight-regulating mechanisms. Now, a new drug on the scene promises to be more effective and safer than any other weight loss drug before.

No comments:

Post a Comment

< + > Key Data Management Efforts to Ensure Your Organization is Ready for AI Solutions

Artificial Intelligence does a lot of incredible things in healthcare – but it is still a newer tool that we need to be careful with. Witho...